Company Profiles

driven by the PitchBook Platform

HyperMed Imaging

Description

Provider of an advanced visualization tool. The company develops medical imaging devices that can be applied in various markets, including diabetes, wound healing, peripheral vascular disease, shock and cancer.

1997

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$1.8M

Latest Deal Amount

$13.6M

Total Amount Raised

Description

Provider of an advanced visualization tool. The company develops medical imaging devices that can be applied in various markets, including diabetes, wound healing, peripheral vascular disease, shock and cancer.

Website:

www.hypermed.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Medical Supplies

Primary Office

41 Second Avenue Burlington, MA 01803United States +1 (203) 769-2349
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore HyperMed Imaging's full profile, request a free trial.

    HyperMed Imaging Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    HyperMed Imaging Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    HyperMed Imaging Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Biomark CapitalVenture CapitalMinority000 0000000 0000
    Burrill & CoMerchant Banking FirmMinority000 0000000 0000
    Biomark Capital Venture Capital
    Burrill & Co Merchant Banking Firm

    HyperMed Imaging Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    David WetherellBiomark CapitalFounder & Managing Director000 0000
    Douglas Lind MDBiomark CapitalManaging Director000 0000
    David Wetherell Founder & Managing Director Biomark Capital
    Douglas Lind MD Managing Director Biomark Capital
    Request full access to PitchBook